ZA969971B - Use of 2-aminobenzothiazoles in the treatment of parkinson's disease and parkinsonian syndromes - Google Patents

Use of 2-aminobenzothiazoles in the treatment of parkinson's disease and parkinsonian syndromes

Info

Publication number
ZA969971B
ZA969971B ZA969971A ZA969971A ZA969971B ZA 969971 B ZA969971 B ZA 969971B ZA 969971 A ZA969971 A ZA 969971A ZA 969971 A ZA969971 A ZA 969971A ZA 969971 B ZA969971 B ZA 969971B
Authority
ZA
South Africa
Prior art keywords
aminobenzothiazoles
parkinson
disease
treatment
parkinsonian syndromes
Prior art date
Application number
ZA969971A
Other languages
English (en)
Inventor
Marie-Christine Dubroeucq
Alain Boireau
Assunta Imperato
Patrick Jimonet
Serge Mignani
John Randle
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA969971B publication Critical patent/ZA969971B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA969971A 1995-12-01 1996-11-27 Use of 2-aminobenzothiazoles in the treatment of parkinson's disease and parkinsonian syndromes ZA969971B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9514239A FR2741803A1 (fr) 1995-12-01 1995-12-01 Application de 2-aminobenzothiazoles dans le traitement de la maladie de parkinson et des syndromes parkinsoniens

Publications (1)

Publication Number Publication Date
ZA969971B true ZA969971B (en) 1997-06-18

Family

ID=9485068

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA969971A ZA969971B (en) 1995-12-01 1996-11-27 Use of 2-aminobenzothiazoles in the treatment of parkinson's disease and parkinsonian syndromes

Country Status (6)

Country Link
EP (1) EP0866703A1 (ja)
JP (1) JP2000505059A (ja)
AU (1) AU7699396A (ja)
FR (1) FR2741803A1 (ja)
WO (1) WO1997020557A1 (ja)
ZA (1) ZA969971B (ja)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826860A (en) * 1987-03-16 1989-05-02 Warner-Lambert Company Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
EP0374041B1 (fr) * 1988-12-15 1992-06-17 Rhone-Poulenc Sante Médicaments à base de dérivés de la benzothiazolamine-2, dérivés et leur préparation

Also Published As

Publication number Publication date
JP2000505059A (ja) 2000-04-25
EP0866703A1 (fr) 1998-09-30
WO1997020557A1 (fr) 1997-06-12
AU7699396A (en) 1997-06-27
FR2741803A1 (fr) 1997-06-06

Similar Documents

Publication Publication Date Title
HUP0100069A3 (en) 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders
HK1015280A1 (en) Use of epinastine in the treatment of pain
NZ314903A (en) A peg-ifn alpha conjugate and its use in the treatment of immunomodulatory disorders
EP0924983A4 (en) S (-) - TOLTERODINE FOR THE TREATMENT OF URINARY AND GASTROINTESTINAL DISORDERS
EP0331620A3 (en) Agent for the treatment of parkinson's disease
AP2001002102A0 (en) Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
ZA978557B (en) Process for the determination of APP secretase modulators and the use thereof as agents in the treatment of a Alzheimer's disease.
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
EP1011644A4 (en) METHOD AND APPARATUS FOR THE TREATMENT OF PARKINSON'S DISEASE
IL160018A0 (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
EP0797440A4 (en) TREATING AUTOIMMUNE DISEASES WITH THE AID OF 2-AMINOPURINE DERIVATIVES
ZA969971B (en) Use of 2-aminobenzothiazoles in the treatment of parkinson's disease and parkinsonian syndromes
AU7622798A (en) Application of thalidomide to the treatment of Parkinson's disease and Parkisonian syndromes
EP0666745A4 (en) METHODS OF DIAGNOSING AND TREATING PARKINSON'S DISEASE.
ZA969968B (en) Use of 2-iminobenzothiazolines in the treatment of parkinson's disease and parkinsonian syndromes
GB9307948D0 (en) Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
AU2137595A (en) Use of arylpiperazine derivatives for the treatment of Parkinson's disease and psychosis
AU8195091A (en) Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease
AU2153092A (en) Spirofurane derivatives and their use in the treatment of neurological disorders
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
ZA947262B (en) Use of transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine and its use for the treatment of alzheimer's disease
AU6955294A (en) Agents for the prevention and treatment of parkinson's disease
FR2700115B1 (fr) Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
AU7442394A (en) Process and device in respect of a three-dimensional body usable in the human body